To train their students, medical schools often require actors to present symptoms of certain pathologies. Offering what is believed to be a more readily available and consistent alternative, the HAL S5301 robot is designed to simulate a patient with a brain injury. Produced by Miami-based Gaumard Scientific, the S5301 is a life-size adult humanoid robot, […]

The US Food and Drug Administration (FDA) has given positive feedback for Algernon Pharmaceuticals’ Phase IIb clinical trial of NP-120 (ifenprodil) for chronic cough treatment. A receptor antagonist of N-methyl-D-aspartate (NMDA), ifenprodil precisely acts on the NMDA-type subunit 2B (GluN2B). The agency offered the feedback at the pre-Investigational New Drug (pre-IND) meeting for the therapy.

For some time now, actors who simulate symptoms of specific diseases have been used to educate medical students. Today a robot called HAL S5301 (Kubrick forgive them) simulates a patient with brain injury: the manufacturing company believes it is a more effective and available alternative. Manufactured by US-based Gaumard Scientific, the S5301 is a life-sized adult humanoid […]